• Vaxcyte EPS for the quarter ending June 30, 2024 was $-1.10, a 57.14% increase year-over-year.
• Vaxcyte 2023 annual EPS was $-4.14, a 20.35% increase from 2022.
• Vaxcyte 2022 annual EPS was $-3.44, a 78.24% increase from 2021.
• Vaxcyte 2021 annual EPS was $-1.93, a 36.09% decline from 2020.

Earnings per share can be defined as a company's net earnings or losses attributable to common shareholders per diluted share base, which includes all convertible securities and debt, options and warrants.